Regulatory Affairs Scopus Indexed Journal
Regulatory affairs Scopus indexed journal
Regulatory affairs also called government affairs, is a profession within regulated industries, such as pharmaceuticals, medical devices, energy, banking, telecom, etc. Regulatory affairs also have a very specific meaning within the healthcare industries (pharmaceuticals, medical devices, biologics, and functional foods). Scopus is a bibliographic database containing abstracts and citations for academic journal articles. It covers nearly 21,000 titles from over 5,000 publishers, of which 20,000 are peer-reviewed journals in the scientific, technical, medical, and social sciences (including arts and humanities). It is owned by Elsevier and is available online by subscription. Searches in Scopus also incorporate searches of patent databases. A journal is a periodical publication intended to further progress of science, usually by reporting new research. Most journals are highly specialized, although some of the oldest journals publish articles, reviews, editorials, short communications, letters, and scientific papers across a wide range of scientific fields. Journals contain articles that peer-reviewed, in an attempt to ensure that articles meet the journal's standards of quality and scientific validity. Each such journal article becomes part of the permanent scientific record.
High Impact List of Articles
-
Policy Change to Adequately Address Monitoring Conduct in a Risk-Based Environment
Laura LaRosa Opinion: Pharmaceutical Regulatory Affairs: Open Access
-
Policy Change to Adequately Address Monitoring Conduct in a Risk-Based Environment
Laura LaRosa Opinion: Pharmaceutical Regulatory Affairs: Open Access
-
Pharmaceutical Good Manufacturing Practice Regulatory Affairs in Sudan: Continuous Debate between Regulatory Authority and Manufacturers
Abubaker Abdellah, M I Noordin, R Zaki and Ali Abedallah Research Article: Pharmaceutical Regulatory Affairs: Open Access
-
Pharmaceutical Good Manufacturing Practice Regulatory Affairs in Sudan: Continuous Debate between Regulatory Authority and Manufacturers
Abubaker Abdellah, M I Noordin, R Zaki and Ali Abedallah Research Article: Pharmaceutical Regulatory Affairs: Open Access
-
Impact of API (Active Pharmaceutical Ingredient) Source Selection on Generic Drug Products
Mallu UR, Nair AK, Sankar J, Bapatu HR, Kumar MP, Narla S, Bhanap TA, Thamma NK and Raman NVVSS Review Article: Pharmaceutical Regulatory Affairs: Open Access
-
Impact of API (Active Pharmaceutical Ingredient) Source Selection on Generic Drug Products
Mallu UR, Nair AK, Sankar J, Bapatu HR, Kumar MP, Narla S, Bhanap TA, Thamma NK and Raman NVVSS Review Article: Pharmaceutical Regulatory Affairs: Open Access
-
On the Multiscale Nature of Human Prostate Cancer
Fabio Grizzi Editorial: Pharmaceutical Regulatory Affairs: Open Access
-
On the Multiscale Nature of Human Prostate Cancer
Fabio Grizzi Editorial: Pharmaceutical Regulatory Affairs: Open Access
Conference Proceedings
-
A new precursor for redox- triggered drug delivery vesicles selective to cancer cells
Tomer Noyhouzer, Isabelle Beaulieu, Stephanie Mazurkiewicz, Sabine Kuss, Janine Mauzeroll, Chloe L Homme, Sylvain Canesi and Heinz-Bernhard Kraatz Posters & Accepted Abstracts: Journal of Formulation Science & Bioavailability
-
A new precursor for redox- triggered drug delivery vesicles selective to cancer cells
Tomer Noyhouzer, Isabelle Beaulieu, Stephanie Mazurkiewicz, Sabine Kuss, Janine Mauzeroll, Chloe L Homme, Sylvain Canesi and Heinz-Bernhard Kraatz Posters & Accepted Abstracts: Journal of Formulation Science & Bioavailability
-
State of the BPCIA after the Supreme Court′s ruling in Amgen v. Sandoz
Joanna T Brougher Posters & Accepted Abstracts: Journal of Bioanalysis & Biomedicine
-
State of the BPCIA after the Supreme Court′s ruling in Amgen v. Sandoz
Joanna T Brougher Posters & Accepted Abstracts: Journal of Bioanalysis & Biomedicine
-
Challenges and approaches in demonstrating biosimilarity at the physicochemical and biological level
Jill A Myers Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
-
Challenges and approaches in demonstrating biosimilarity at the physicochemical and biological level
Jill A Myers Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
-
Varied virological response of patients with chronic hepatitis c against the treatment of pegylated interferon-α and ribavarin
Mohammed Nomaan Ilyas, Salman Junaid, Mubasheer khan, Rizwan masood and Syed Aamir ali Posters: Journal of Bioanalysis & Biomedicine
-
Varied virological response of patients with chronic hepatitis c against the treatment of pegylated interferon-α and ribavarin
Mohammed Nomaan Ilyas, Salman Junaid, Mubasheer khan, Rizwan masood and Syed Aamir ali Posters: Journal of Bioanalysis & Biomedicine
-
Integrated strategy for biosimilar development: A multidisciplinary approach for risk reduction
Adriana E. Manzi Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
-
Integrated strategy for biosimilar development: A multidisciplinary approach for risk reduction
Adriana E. Manzi Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Relevant Topics in Pharmaceutical Sciences